Related Experiment Videos
Diagnosis and case finding in familial hypercholesterolemia
1M.I. Bassett Research Institute, Cooperstown, New York 13326.
The American Journal of Cardiology
|September 30, 1993
Summary
Heterozygous familial hypercholesterolemia (hFH) poses a high coronary disease risk. Current screening methods fail to identify most hFH cases, necessitating improved strategies and physician awareness.
Area of Science:
- Cardiology
- Genetics
- Public Health
Background:
- Heterozygous familial hypercholesterolemia (hFH) significantly elevates coronary disease risk.
- Despite its risks, hFH diagnosis and case finding face challenges.
Purpose of the Study:
- To evaluate if hFH meets World Health Organization criteria for screening.
- To identify barriers in current hFH screening strategies and propose solutions.
Main Methods:
- Review of existing hFH identification strategies.
- Analysis of barriers hindering screening implementation.
- Assessment of hFH against WHO screening criteria.
Main Results:
- hFH meets WHO criteria for a screening program.
- Current strategies (e.g., universal cholesterol testing, family screening, premature event screening) are largely unsuccessful in identifying hFH cases.
- Significant barriers exist for both patients and physicians in executing screening recommendations.
Conclusions:
- hFH warrants a dedicated screening approach due to its high cardiovascular risk.
- Existing screening strategies are insufficient for widespread hFH case detection.
- Overcoming barriers, including enhancing primary care provider awareness, is crucial for effective hFH identification.